Werner Lubitz

This inventor holds 17 USPTO granted patents, plus 2 CIPO patents and 7 EPO patents, primarily in Bacterial Technology. Top assignees: Swiss Analyze Bacteria Ag, Bird-C Gmbh, Bird-C Gmbh & Co Kg. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Werner Lubitz. Retrieved from https://idiyas.com/inventor/werner-lubitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 47.1

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 23(Granted Patents)

Location History:

Wien/Vienna, AT (2003 - 2004)
1080 Vienna, AT (2003 - 2005)
Vienna, AT (2005)
1080 Wien, Österreich, AT (2008)
Kirtzendorf, AT (2014)
Klosterneuburg/Kritzendorf, AU (2017)
Klosterneuburg/Kritzendorf, AT (2013 - 2020)
Kritzendorf, AT (2010 - 2024)

Company Filing History:

2 out of 2

Swiss Analyze Bacteria Ag

4. 13 out of 834,570

Other

patents

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

Bacterial Ghosts

Tumor Immunotherapy

Minicircle Vector

Gene Expression

Vaccine Development

Rapid Testing

Innate Immunity

Recombinant Proteins

Bioaffinity Interactions

Thermostable Mutants

Polypeptide Compartmentalization

Secretion Mechanisms

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11906497 - Rapid bacteria test (2024-02-20),

2. 10823719 - Rapid test for bacteria (2020-11-03),

3. 10772944 - Bacterial ghosts for the treatment of cancer (2020-09-15),

4. 10526574 - Fed-batch process for the production of bacterial ghosts (2020-01-07),

5. 9790260 - Vaccine for tumor immunotherapy (2017-10-17),

6. 9415017 - Bacterial ghosts for mediating innate immunity (2016-08-16),

7. 8911974 - Minicircle vector production (2014-12-16),

8. 8647863 - Minicircle vector production (2014-02-11),

9. 8568738 - Virus-modified bacteria ghosts (2013-10-29),

10. 7968323 - Bacterial ghost (BG) production process using betapropiolactone (BPL) for final inactivation (2011-06-28),

11. 7709260 - Sealing closure of bacterial ghosts by means of bioaffinity interactions (2010-05-04),

12. 7332323 - [object Object] (2008-02-19),

13. 6964845 - Thermostable phage lambda operator mutants for regulating gene expression (2005-11-15),

14. 6951756 - Closure of bacterial ghost (2005-10-04),

15. 6777202 - Recombinant expression of S-layer proteins (2004-08-17),

Title: The Innovative Mind of Werner Lubitz

Introduction

Werner Lubitz, an accomplished inventor hailing from Kritzendorf, Austria, has made significant contributions to the field of microbiology through his inventive prowess. With a remarkable portfolio of 17 patents, he is recognized for developing rapid testing methods for bacteria, aiding in the swift diagnosis and understanding of bacterial infections.

Latest Patents

Werner's most recent patents include the "Rapid Bacteria Test," which pertains to methods and devices designed for the quantitative determination of bacteria. Additionally, his patent for a "Rapid Test for Bacteria" further enhances the techniques available in bacterial enumeration. These innovations reflect his commitment to advancing medical diagnostics and research in microbiology.

Career Highlights

Throughout his career, Werner Lubitz has been associated with notable companies that specialize in microbiological solutions, including Swiss Analyze Bacteria AG. His work at these institutions has significantly shaped his research direction, leading to impactful innovations in the field.

Collaborations

Werner has collaborated with distinguished professionals like Wolfgang Jechlinger and Dieter Ebert, sharing insights and expertise that have fostered the development of his innovative ideas. Such collaborations have enriched his projects and enhanced the outcomes of his inventions.

Conclusion

Werner Lubitz's contributions to the field of microbiology through his patents on rapid bacteria testing showcase his innovative spirit and dedication to improving diagnostic methods. As he continues his work, his inventions promise to have a lasting impact on both the scientific community and public health.

Profile summary based on public USPTO records.